Evidence map›Paper›PMID 39373228›Full record

ArticleEuropean journal of clinical investigation2025

A newly developed, easy-to-use prehospital drug-derived score compared with three conventional scores: A prospective multicenter study.

Jesús Jurado-Palomo, José Luis Martin-Conty, Begoña Polonio-López, Juan J Bernal-Jiménez, Rosa Conty-Serrano, Michele Dileone, Miguel A Castro Villamor, Carlos Del Pozo Vegas, Raúl López-Izquierdo, Cristina Rivera-Picón and 2 more

Abstract readMulticenter StudyComparative Study
In one paragraph

Article in European journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jesús Jurado-PalomoHospital General Nuestra Señora del Prado, Talavera de la Reina, Spain.
José Luis Martin-ContyFaculty of Health Sciences, University of Castilla la Mancha, Talavera de la Reina, Spain.ORCID https://orcid.org/0000-0001-8579-2323
Begoña Polonio-LópezFaculty of Health Sciences, University of Castilla la Mancha, Talavera de la Reina, Spain.
Juan J Bernal-JiménezFaculty of Health Sciences, University of Castilla la Mancha, Talavera de la Reina, Spain.
Rosa Conty-SerranoFaculty of Nursing, University of Castilla-La Mancha, Toledo, Spain.
Michele DileoneHospital General Nuestra Señora del Prado, Talavera de la Reina, Spain.
Miguel A Castro VillamorFaculty of Medicine, Universidad de Valladolid, Valladolid, Spain.
Carlos Del Pozo VegasFaculty of Medicine, Universidad de Valladolid, Valladolid, Spain.
Raúl López-IzquierdoFaculty of Medicine, Universidad de Valladolid, Valladolid, Spain.
Cristina Rivera-PicónFaculty of Health Sciences, University of Castilla la Mancha, Talavera de la Reina, Spain.ORCID https://orcid.org/0000-0001-7031-2585
Francisco Martín-RodríguezPrehospital Critical Care, Emergency Medical Services. Gerencia Regional de Salud de Castilla y León, Valladolid, Spain.
Ancor Sanz-GarcíaTechnological Innovation Applied to Health Research Group (ITAS Group), Faculty of Health Sciences, University of de Castilla-La Mancha, Talavera de la Reina, Spain.

Funding

Instituto de Salud Carlos IIIUnión Europea DTS23/00010
6 · The paper itself

Abstract

introductionThe use of medications by emergency medical services (EMS) is increasing. Conventional scores are time-consuming and therefore difficult to use in an emergency setting. For early decision-making, an easy-to-use score based on the medications administered by the EMS may have prognostic value. The primary objective of this study was to develop the prehospital drug-derived score (PDDS) for 2-day mortality.

methodsA prospective, multicenter, ambulance-based cohort study was conducted in adults with undifferentiated acute diseases treated by EMS and transferred to the emergency department. Demographic data, prehospital diagnosis data, prehospital medication and variables for the calculation of the National Early Warning Score 2 (NEWS2), Rapid Emergency Medicine Score (REMS), and Rapid Acute Physiology Score (RAPS) were collected. The PDDS was developed and validated, establishing three levels of risk of 2-day mortality. The predictive capability of each score was determined by the area under the curve of the receiver operating characteristic curve (AUROC) and compared using the Delong's test (p-value).

resultsA total of 6401 patients were included. The PDDS included age and the use of norepinephrine, analgesics, neuromuscular blocking agents, diuretics, antihypertensive agents, tranexamic acid, and bicarbonate. The AUROC of PDDS was .86 (95% CI: .816-.903) versus NEWS2 .866 (95% CI: .822-.911), p = .828; versus REMS .885 (95% CI: .845-.924), p = .311; versus RAPS .886 (95% CI: .846-.926), p = .335, respectively.

conclusionThe newly developed easy-to-use prehospital drug-derived PDDS score has an excellent predictive value of early mortality. The PDDS score was comparable to the conventional risk scores and therefore might serve as an alternative score in the prehospital emergency setting.

Indexed as

Emergency Medical ServicesROC CurveTranexamic AcidAdultAgedAged, 80 and overAnalgesicsAntihypertensive AgentsArea Under CurveDiureticsEarly Warning ScoreFemaleHumansMaleMiddle AgedMortalityAnalgesicsAntihypertensive AgentsDiureticsTranexamic Acidacute diseaseemergency medical servicesmortalitypoint‐of‐care medicationrisk assessment

Identifiers

PMID39373228
PMCPMC11628643

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.